Article Details

FDA authorizes Roche drug for severely ill COVID-19 patients

Retrieved on: 2021-06-25 17:48:45

Tags for this article:

Click the tags to see associated articles and topics

FDA authorizes Roche drug for severely ill COVID-19 patients. View article details on hiswai:

Excerpt

Trial data suggested infusions of Roche's Actemra (tocilizumab) cut length of hospital stay and reduced the risk of death and ventilation after 28 days.

Article found on: www.foxnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo